Companies: 10,304     total market cap: S$155.104 T
🇩🇪 Deutsch🇫🇷 Français
$USD🇺🇸€EUR🇪🇺₹INR🇮🇳£GBP🇬🇧$CAD🇨🇦$AUD🇦🇺$NZD🇳🇿$HKD🇭🇰
Exelixis
EXEL
#1696
Rank
S$13.36 B
Marketcap
🇺🇸 United States
Country
$46.81
Share price
-3.83%
Change (1 day)
50.44%
Change (1 year)
💊 Pharmaceuticals🧬 Biotech
Categories
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2024 (TTM): S$0.79 Billion

According to Exelixis's latest financial reports the company's current earnings are S$2.08 Billion. In 2023 the company made an earning of S$0.34 Billion, an increase over its 2022 earnings that were of S$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.79 B129.63%
2023 S$0.34 B9.89%
2022 S$0.31 B-20.33%
2021 S$0.39 B124.82%
2020 S$0.17 B-67.14%
2019 S$0.53 B-11.94%
2018 S$0.61 B185.09%
2017 S$0.21 B-325.82%
2016 -S$94.76 Million-58.12%
2015 -S$0.23 Billion-37.61%
2014 -S$0.37 Billion9.75%
2013 -S$0.34 Billion65.96%
2012 -S$0.2 Billion-291.63%
2011 S$0.10 B-195.59%
2010 -S$0.11 Billion-42.17%
2009 -S$0.19 Billion-18.98%
2008 -S$0.24 Billion-6.99%
2007 -S$0.25 Billion46.3%
2006 -S$0.18 Billion33.25%
2005 -S$0.13 Billion-30.92%
2004 -S$0.19 Billion44.29%
2003 -S$0.13 Billion12.86%
2002 -S$0.12 Billion22.79%
2001 -S$92.63 Million60.14%
2000 -S$57.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
GlaxoSmithKline
GSK
S$5.62 B 595.25%🇬🇧 UK
Sanofi
SNY
S$9.99 B 1,134.83%🇫🇷 France
Merck
MRK
S$20.20 B 2,395.89%🇺🇸 USA
Bristol-Myers Squibb
BMY
-S$9.29 Billion-1,246.85%🇺🇸 USA
Amgen
AMGN
S$6.31 B 679.96%🇺🇸 USA
Johnson & Johnson
JNJ
S$24.82 B 2,966.31%🇺🇸 USA
Pfizer
PFE
S$9.36 B 1,057.35%🇺🇸 USA
Curis
CRIS
-S$60.47 Million-107.47%🇺🇸 USA
AVEO Oncology
AVEO
-S$39.19 Million-104.84%🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2024 CompaniesMarketcap.com